{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:56:40Z","timestamp":1760983000767},"reference-count":75,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.ejso.2009.01.010","type":"journal-article","created":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T05:45:55Z","timestamp":1235627155000},"page":"1137-1145","source":"Crossref","is-referenced-by-count":7,"title":["The role of PET in the surgical approach to adrenal disease"],"prefix":"10.1016","volume":"35","author":[{"given":"M.D.","family":"Gross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.G.","family":"Gauger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Djekidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2009.01.010_bib1","series-title":"Endocrinology","first-page":"2425","article-title":"Adrenal gland imaging","author":"Gross","year":"2005"},{"key":"10.1016\/j.ejso.2009.01.010_bib2","unstructured":"Gross MD, Wong K-K, Rubello D. Scintigraphic imaging of adrenal disease. Minerva Endocrinol; in press."},{"key":"10.1016\/j.ejso.2009.01.010_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0039-128X(70)80116-7","article-title":"Tumor localizing agents. Ix. Radioiodinated cholesterol","volume":"16","author":"Counsell","year":"1970","journal-title":"Steroids"},{"key":"10.1016\/j.ejso.2009.01.010_bib4","first-page":"176","article-title":"Radiolabeled cholesterol as an adrenal scanning agent","volume":"12","author":"Blair","year":"1971","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.1971.03180280029005","article-title":"Visualization of human adrenal glands by in vivo scintillation scanning","volume":"216","author":"Beierwaltes","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2009.01.010_bib6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/jlcr.2590110318","article-title":"Synthesis of a new adrenal cortex imaging agent 6-131I-iodomethyl-19-norcholest-5(10)-en-3-ol (NP-59)","volume":"11","author":"Basmadjian","year":"1975","journal-title":"J Labeled Compd"},{"key":"10.1016\/j.ejso.2009.01.010_bib7","first-page":"1038","article-title":"A new and superior adrenal scanning agent, NP-59","volume":"16","author":"Sarkar","year":"1975","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib8","first-page":"23","article-title":"Adrenal scintigraphy","volume":"18","author":"Thrall","year":"1978","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2265.1981.tb02743.x","article-title":"Clinical experience with 75Se-selenomethylnorcholesterol adrenal imaging","volume":"15","author":"Shapiro","year":"1981","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejso.2009.01.010_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0969-8051(98)00081-X","article-title":"Synthesis, biological evaluation, and baboon PET imaging of the potential adrenal imaging agent cholesteryl-p-[18F]fluorobenzoate","volume":"26","author":"Jonson","year":"1999","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.ejso.2009.01.010_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0001-2998(78)80004-X","article-title":"Adrenal imaging agents: rationale, synthesis, formulation and, metabolism","volume":"8","author":"Beierwaltes","year":"1978","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/er.2003-0032","article-title":"Functional imaging of endocrine tumors: role of positron emission tomography","volume":"25","author":"Pacak","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejso.2009.01.010_bib13","first-page":"972","article-title":"Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG","volume":"45","author":"Minn","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib14","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00259-004-1575-0","article-title":"Positron emission tomography imaging of adrenal masses: 18F-fluorodeoxyglucose and the 11\u03b2-hydroxylase tracer 11C-metomidate","volume":"31","author":"Zettinig","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejso.2009.01.010_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00259-005-0062-6","article-title":"[18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers","volume":"33","author":"Wadsak","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejso.2009.01.010_bib16","first-page":"260","article-title":"Positron emission tomography in the diagnostic evaluation of adrenal tumors","volume":"51","author":"Gross","year":"2007","journal-title":"Q J Nuclear Med Mol Imaging"},{"key":"10.1016\/j.ejso.2009.01.010_bib17","first-page":"93","article-title":"Labeled dopamine concentration in human adrenal medulla and in neuroblastoma","volume":"10","author":"Lieberman","year":"1969","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib18","first-page":"781","article-title":"Labeled dopamine concentration in pheochromocytomas","volume":"14","author":"Anderson","year":"1973","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1021\/jm00225a002","article-title":"Radiopharmaceuticals. Halogenated dopamine analogs: synthesis and radiolabeling of 6-iododopamine and tissue distribution studies in animals","volume":"19","author":"Fowler","year":"1976","journal-title":"J Med Chem"},{"key":"10.1016\/j.ejso.2009.01.010_bib20","first-page":"87","article-title":"Aradioiodinated bretylium analog as a potential agent for scanning the adrenal medulla","volume":"18","author":"Korn","year":"1977","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib21","first-page":"349","article-title":"Radiolabeled adrenergic neuron blocking agents: adrenal medulla imaging with (131I) iodobenzylguanidine","volume":"21","author":"Wieland","year":"1980","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib22","first-page":"358","article-title":"Imaging the primate adrenal medulla with (123I) and (131I) metaiodobenzylguanidine","volume":"22","author":"Wieland","year":"1981","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1056\/NEJM198107023050103","article-title":"Scintigraphic localization of pheochromocytoma","volume":"305","author":"Sisson","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.7326\/0003-4819-94-6-762","article-title":"Spectrum of pheochromocytoma in multiple endocrine neoplasia: a scintigraphic portrayal using 131-I-metaiodobenzylguanidine","volume":"94","author":"Valk","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib25","first-page":"672","article-title":"The normal and abnormal distribution of the adrenomedullary imaging agent I-131-metaiodobenzylguanidine (I-MIBG) in man: evaluation by scintigraphy","volume":"24","author":"Nakajo","year":"1983","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1196\/annals.1353.050","article-title":"Malignant pheochromocytomas and paragangliomas. A phase II study of therapy with high dose 131I-metaiodobenzlyguanidine (131I-MIBG)","volume":"1073","author":"Fitzgerald","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ejso.2009.01.010_bib27","first-page":"1328","article-title":"Synthesis and preliminary evaluation of (11C) metahydroxyephedrine: a false neurotransmitter agent for heart neuronal imaging","volume":"31","author":"Rosenspire","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.82.2.457","article-title":"The noninvasive evaluation of the sympathetic nervous system in the human heart by PET","volume":"82","author":"Schwaiger","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ejso.2009.01.010_bib29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1196\/annals.1294.032","article-title":"Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors","volume":"1014","author":"Nilsson","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ejso.2009.01.010_bib30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1196\/annals.1296.061","article-title":"Anatomical and functional imaging of metastatic pheochromocytoma","volume":"1018","author":"Ilias","year":"2004","journal-title":"Ann New York Acad Sci"},{"key":"10.1016\/j.ejso.2009.01.010_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.2002.tb04422.x","article-title":"The role of PET in the localization of neuroendocrine and adrenocortical tumors","volume":"970","author":"Eriksson","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ejso.2009.01.010_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1053\/j.semnuclmed.2006.03.007","article-title":"Imaging of neuroendocrine tumors","volume":"36","author":"Ruffini","year":"2006","journal-title":"Sem Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib33","first-page":"685","article-title":"123I-metaiodobenzylguanidine and 111In-octreotide uptake in benign and malignant pheochromocytomas","volume":"86","author":"Van der Harst","year":"2001","journal-title":"J Clin Endo Metab"},{"key":"10.1016\/j.ejso.2009.01.010_bib34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.rlu.0000255027.70167.cf","article-title":"Cardiac pheochromocytomas detected by Tc-99m-Hydrazinonicotinyl-Tyr3-Octreotide (HYNIC-TOC) scintigraphy","volume":"32","author":"Chen","year":"2007","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MNM.0b013e32808ea0b0","article-title":"68Ga-DOTATATE PET in neuroectodermal tumours: first experience","volume":"28","author":"Win","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejso.2009.01.010_bib36","first-page":"1795","article-title":"18F-FDG PET in characterizing adrenal lesions detected on CT or MRI","volume":"42","author":"Yun","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib37","first-page":"32","article-title":"18F-FDG PET\/CT in the evaluation of adrenal masses","volume":"47","author":"Metser","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00259-002-1025-9","article-title":"11C-metomidate imaging of adrenocortical cancer","volume":"30","author":"Khan","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejso.2009.01.010_bib39","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1210\/jc.2005-2273","article-title":"[11C]Metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings","volume":"91","author":"Hennings","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2009.01.010_bib40","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2005-2612","article-title":"Use of [18F]-fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma","volume":"91","author":"Mackie","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2009.01.010_bib41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1530\/eje.0.1500789","article-title":"18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for maliganacy of adrenocortical tumors? Preliminary results in 13 consecutive patients","volume":"150","author":"Tenenbaum","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejso.2009.01.010_bib42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF03351068","article-title":"Adrenal tumors: how to establish malignancy?","volume":"27","author":"Fassnacht","year":"2004","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.ejso.2009.01.010_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.rlu.0000124008.68606.4c","article-title":"F-18 fluorodeoxyglucose positron emission tomography-positive benign adrenal cortical adenoma: imaging features and pathologic correlation","volume":"29","author":"Rao","year":"2004","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib44","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.acra.2007.01.009","article-title":"Differentiating adrenal adenomas from nonadenomas using 18F-FDG PET\/CT: quantitative and qualitative evaluation","volume":"14","author":"Caroili","year":"2007","journal-title":"Acad Radiol"},{"key":"10.1016\/j.ejso.2009.01.010_bib45","doi-asserted-by":"crossref","unstructured":"White ML, Cho KJ, Gauger PG. et al. The role of radiologic studies in the evaluation and management of primary hyperaldosteronism, Surgery; in press.","DOI":"10.1016\/j.surg.2008.07.025"},{"key":"10.1016\/j.ejso.2009.01.010_bib46","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejso.2009.01.010_bib47","first-page":"884","article-title":"The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses","volume":"42","author":"Maurea","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib48","first-page":"188","article-title":"Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques","volume":"48","author":"Maurea","year":"2004","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejso.2009.01.010_bib49","first-page":"74","article-title":"Diagnosis of adrenal disease on PET\/CT studies by standard uptake value measurement","volume":"33","author":"Houseni","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1677\/erc.1.01029","article-title":"Management of patients with adrenal cancer. Recommendation of an international consensus conference","volume":"12","author":"Schteingart","year":"2005","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2009.01.010_bib51","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF03006609","article-title":"High [18F] 2-fluoro-2-deoxy-d-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome","volume":"17","author":"Shimizu","year":"2003","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib52","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1148\/rg.266065057","article-title":"Integrated PET\/CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficiacy and interpretation pitfalls","volume":"26","author":"Chong","year":"2006","journal-title":"Radiographics"},{"key":"10.1016\/j.ejso.2009.01.010_bib53","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/rg.273055031","article-title":"Improved detection and characterization of adrenal disease with PET-CT","volume":"27","author":"Elaini","year":"2007","journal-title":"Radiographics"},{"key":"10.1016\/j.ejso.2009.01.010_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1677\/ERC-07-0045","article-title":"The optimal imaging of adrenal tumours: a comparison of different methods","volume":"14","author":"Ilias","year":"2007","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.ejso.2009.01.010_bib55","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1196\/annals.1353.041","article-title":"Current trends in functional imaging of pheochromocytomas and paragangliomas","volume":"1073","author":"Shulkin","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ejso.2009.01.010_bib56","first-page":"1265","article-title":"Experience with the use of 131-I-metaiodobenzylguanidine for locating pheochromocytomas","volume":"vol. II","author":"Shapiro","year":"1982"},{"key":"10.1016\/j.ejso.2009.01.010_bib57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.1984.tb00074.x","article-title":"Malignant pheochromocytoma: clinical, biochemical and scintigraphic characterization","volume":"20","author":"Shapiro","year":"1984","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejso.2009.01.010_bib58","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1200\/JCO.2006.09.6297","article-title":"Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated peochromocotma and paprganglioma","volume":"25","author":"Timmers","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2009.01.010_bib59","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2967\/jnumed.108.052373","article-title":"Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111In-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma","volume":"49","author":"Ilias","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiology.212.1.r99jl3035","article-title":".Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET","volume":"212","author":"Shulkin","year":"1999","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejso.2009.01.010_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.mnm.0000189780.54658.e8","article-title":"Discordant localization of 2-[18F]-fluoro-2-deoxy-d-glucose in 6-[18F]-fluorodopamine- and [123I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites","volume":"27","author":"Mamede","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejso.2009.01.010_bib62","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.tem.2005.01.007","article-title":"New functionqal imaging modalities for chromaffin tumors, neuroblastoma and ganglioneuromas","volume":"16","author":"Ilias","year":"2005","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.ejso.2009.01.010_bib63","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1148\/radiol.2302021678","article-title":"Pheochromocytomas: detection with 11C Hydroxyephedrine PET","volume":"230","author":"Trampal","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2009.01.010_bib64","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1210\/jc.2003-030235","article-title":"Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintography in the localization of metastatic pheochromocytoma","volume":"88","author":"Ilias","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2009.01.010_bib65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/EJE-07-0369","article-title":"The use of 18-fluoro-dihydroxyphenalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma","volume":"157","author":"Mackenzie","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejso.2009.01.010_bib66","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2967\/jnumed.107.042721","article-title":"The effects of carbidopa on uptake on 6-18F-Fluoro-l-DOPA in PET of Pheochromocytoma and extraadrenal abdominal paraganglioma","volume":"48","author":"Timmers","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib67","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1055\/s-2005-921091","article-title":"Diagnosis and management of tumors of the adrenal medulla","volume":"37","author":"Ilias","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ejso.2009.01.010_bib68","first-page":"150","article-title":"Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors","volume":"48","author":"Bombardieri","year":"2004","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib69","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0039-6060(03)00416-1","article-title":"Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?","volume":"134","author":"Miskulin","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2009.01.010_bib70","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1245\/s10434-007-9776-y","article-title":"The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma","volume":"15","author":"Greenblatt","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2009.01.010_bib71","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/EJE-06-0712","article-title":"The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with Von Hipple\u2013Lindau syndrome","volume":"156","author":"Kaji","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejso.2009.01.010_bib72","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1001\/archinte.1982.00340250050010","article-title":"The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis","volume":"142","author":"Kalff","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib73","series-title":"Neuroblastoma","first-page":"171","article-title":"Radioiodinated meta-iodobenzylguanidine in the management of neuroblastoma","author":"Shulkin","year":"1990"},{"key":"10.1016\/j.ejso.2009.01.010_bib74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0001-2998(05)80104-7","article-title":"Metaiodobenzylguanidine in children","volume":"23","author":"Gelfand","year":"1993","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.ejso.2009.01.010_bib75","first-page":"220","article-title":"PET studies of neuroblastoma with carbon 11-hydroxyephedrine","volume":"33","author":"Shulkin","year":"1993","journal-title":"J Nucl Med"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798309000304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798309000304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T05:56:49Z","timestamp":1545371809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798309000304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0748798309000304"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2009.01.010","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}